Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Rikako Hashimoto"'
Autor:
Rikako Hashimoto, Sadako Akashi-Tanaka, Chie Watanabe, Hiroko Masuda, Kanae Taruno, Tomoko Takamaru, Yoshimi Ide, Takashi Kuwayama, Yasuhiro Kobayashi, Masafumi Takimoto, Seigo Nakamura
Publikováno v:
Breast cancer (Tokyo, Japan). 29(6)
Background Dedicated breast positron emission tomography (dbPET) has been developed for detecting smaller breast cancer. We investigated the diagnostic performance of dbPET in patients with known breast cancer. Methods Eighty-two preoperative patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d076d56eed4bd3598cdcff69ec7f809b
https://pubmed.ncbi.nlm.nih.gov/35768684
https://pubmed.ncbi.nlm.nih.gov/35768684
Publikováno v:
Applications of FDG PET in Oncology ISBN: 9789811584220
The roles of FDG PET in breast cancer patients include staging, recurrence assessment, evaluation of response to chemotherapy, and prognosis prediction. Both sensitivity and specificity of FDG PET for breast cancer detection is over 80%, respectively
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d775f308c7119987b36360b65a8c9167
https://doi.org/10.1007/978-981-15-8423-7_3
https://doi.org/10.1007/978-981-15-8423-7_3
Autor:
Seigo Nakamura, Lei Liu, Arisa Ata, Hiroko Masuda, Yuki Matsunaga, Hiromi Okuyama, Junji Tsurutani, Terumasa Sawada, Sayuka Nakayama, Chie Watanabe, Yumi Tonouchi, Rikako Hashimoto, Yoshimi Ide, Mayuko Inuzuka, Takashi Kuwayama, Sadako Akashi-Tanaka, Kanae Taruno
Publikováno v:
Scientific Reports
BRCAness is defined as a phenotypic copy of germline BRCA mutations, which describes presence of homologous recombination defects in sporadic cancers. We detected BRCAness by multiplex ligation-dependent probe amplification (MLPA) and explored whethe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::594bf87d55f8193a02fa3ecc3e95a9ba
http://europepmc.org/articles/PMC7713365
http://europepmc.org/articles/PMC7713365
Autor:
Katsutoshi Enokido, Reiko Yoshida, Megumi Nakajima, Yuko Hirota, Murasaki Ikeda, Seigo Nakamura, Sadako Akashi-Tanaka, Rikako Hashimoto, Takashi Kuwayama, Terumasa Sawada, Yoko Kanada, Hiroto Oyama
Publikováno v:
The Showa University Journal of Medical Sciences. 27:131-136
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9381827b0d2005ddb9d07652403673ac
https://doi.org/10.15369/sujms.27.131
https://doi.org/10.15369/sujms.27.131
Publikováno v:
An Official Journal of the Japan Primary Care Association. 37:99-103
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3670bb0f2c959b25784ab645da7fe823
https://doi.org/10.14442/generalist.37.99
https://doi.org/10.14442/generalist.37.99
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 75:1772-1776
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6fb18280a367e06c630eacb0e1b44560
https://doi.org/10.3919/jjsa.75.1772
https://doi.org/10.3919/jjsa.75.1772
Autor:
Takashi Kuwayama, Seigo Nakamura, Tomoko Takamaru, Rikako Hashimoto, Hiroko Masuda, Yuko Hirota, Masanori Hirose, Yoshimi Ide, Terumasa Sawada, Y. Kobayashi, Kanae Taruno, Chie Watanabe, Sadako Akashi-Tanaka
Publikováno v:
Annals of Oncology. 28:v452
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40a25fd956cd4a449d463a5c7c958a7f
https://doi.org/10.1093/annonc/mdx378.011
https://doi.org/10.1093/annonc/mdx378.011
Autor:
Sadako Akashi-Tanaka, Chie Watanabe, Tomoko Takamaru, Takashi Kuwayama, Murasaki Ikeda, Hiroto Ohyama, Miki Mori, Reiko Yoshida, Rikako Hashimoto, Sawada Terumasa, Katsutoshi Enokido, Yuko Hirota, Hiromi Okuyama, Seigo Nakamura
Publikováno v:
Clinical Breast Cancer; Feb2015, Vol. 15 Issue 1, p80-85, 6p
Autor:
Takashi Kuwayama, Sadako Akashi-Tanaka, Miki Mori, Tomoko Takamaru, Hiroto Ohyama, Sawada Terumasa, Hiromi Okuyama, Katsutoshi Enokido, Yuko Hirota, Seigo Nakamura, Reiko Yoshida, Rikako Hashimoto, Murasaki Ikeda, Chie Watanabe
Publikováno v:
Clinical Breast Cancer. (1):80-85
Background To provide optimal treatment of heterogeneous triple negative breast cancer (TNBC), we need biomarkers that can predict the chemotherapy response. Patients and Methods We retrospectively investigated BRCAness in 73 patients with breast can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88e720bc1a1a3facc314e9e2857f1836